Also, in murine 4T1 breast adenocarcinoma, Crk knockout effectively diminished both EMT and PD-L1 expression, leading to an additive effect alongside anti-PD1 therapy in curtailing tumor growth [101]. This evidence concerns the gene CRK and breast adenocarcinoma.